Adside 50 mg Capsule
Request Pricing & Availability
Fill in your details below and our clinical team will get back to you with pricing & availability within 24 hours.
Similar Products
| Product | Manufacturer / Marketed By | Price |
|---|---|---|
Posid 50 mg Capsule
|
Cadila Pharmaceuticals Ltd | Ask for Price |
Etoplast 50 mg Capsule
|
— Not specified | Ask for Price |
Vepesid Injection
|
Bristol Myers Squibb | Ask for Price |
About our medical review process
Dr. Sophie Reynolds Dr. Sophie Reynolds is a board-certified medical doctor specializing in internal medicine. With over a decade of experience in patient care and medical writing
Benefits
-
Slows or stops cancer cell growth
-
Effective as part of combination chemotherapy regimens
-
Improves treatment response and survival outcomes
-
Oral capsule offers convenient administration
Indications and Usage
Adside Etoposide 50mg Capsule is indicated for:
-
Small Cell Lung Cancer (SCLC)
-
Testicular Cancer
-
May be used in other solid tumors or hematologic cancers as prescribed
Treatment must be initiated and supervised by an oncology specialist.
How it Works
Etoposide blocks topoisomerase II, an enzyme cancer cells need for DNA replication. This prevents cell division and leads to cancer cell death, helping slow tumor growth.
Dosage & Administration
-
Typical dose: based on body surface area (BSA) and treatment plan
-
Usually taken once or twice daily for several days in a chemotherapy cycle
-
Swallow capsules whole with water—do not crush or chew
-
Can be taken with or without food, unless advised otherwise
-
Do not stop or change the dose without medical guidance
-
Routine blood tests required to monitor counts and organ function
Use only under oncologist supervision.
Side Effects
Common side effects:
-
Nausea, vomiting
-
Loss of appetite
-
Fatigue or weakness
-
Hair loss
-
Low blood cell counts
Serious side effects (seek urgent care):
-
Severe infection or fever
-
Unusual bleeding or bruising
-
Allergic reactions
-
Liver dysfunction
-
Severe stomach or chest pain
Warning and Precaution
-
Not recommended during pregnancy or breastfeeding
-
May cause severe bone marrow suppression—monitor blood counts regularly
-
Inform doctor if you have liver, kidney, or heart disease
-
Increased infection and bleeding risk
-
Avoid live vaccines during treatment
-
Report fever, bleeding, shortness of breath, or jaundice immediately
Related Products
-
Zyceva 100 mg Tablet
ErlotinibPrice on request
Request pricing -
Imatikast 400 mg Tablet
ImatinibPrice on request
Request pricing -
Pomalid 1 Mg Capsule
PomalidomidePrice on request
Request pricing -
Pomalid 2 Mg Capsule
PomalidomidePrice on request
Request pricing -
Pazonat 200 mg Tablet
PazopanibPrice on request
Request pricing -
CA Atra 10 mg Softgel Capsule
TretinoinPrice on request
Request pricing -
Sutinat 25 mg Capsule
SunitinibPrice on request
Request pricing -
Sutinat 12.5 mg Capsule
SunitinibPrice on request
Request pricing -
Spnib 100 mg Tablet
DasatinibPrice on request
Request pricing -
Azatend 100 mg Injection
AzacitidinePrice on request
Request pricing -
Tegonat 15 mg Capsule
TegafurPrice on request
Request pricing -
Bdenza 40 mg Capsule
EnzalutamidePrice on request
Request pricing
Related Reading
-
Ruxolitinib Tablets Receive FDA Approval for Hematologic Malignancies
The U.S. Food and Drug Administration (FDA) has approved Ruxolitinib tablets for the treatment of certain hematologic malignancies, marking another
-
Tovorafenib Approved in Europe for Children with BRAF-Altered Low-Grade Glioma
Medical Review: This article was reviewed by Dr. Sophie Reynolds on May 14, 2026. n This marks an important milestone
-
FDA Fast-Tracks Plixorafenib for BRAF V600E–Mutated Brain Tumors
Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 14, 2026. n Brain tumors, especially high-grade gliomas,
-
What are the 4 stages of lung cancer?
Medical Review: This article was reviewed by Dr. Sophie Reynolds on April 7, 2026. n Lung cancer staging is a
-
Sunvozertinib vs Chemo: A PFS Breakthrough in EGFR+ NSCLC
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 25, 2026. n The treatment landscape for EGFR-mutated
-
Atirmociclib and Fulvestrant Together Delay Cancer Progression in HR+/HER2– Cases
Medical Review: This article was reviewed by Dr. Sophie Reynolds on March 23, 2026. Advancements in breast cancer treatment continue
Shipping & Delivery
- Ships from
- India, worldwide delivery
- Order processing
- 1–3 business days after checks
- Transit time
- 5–7 business days by express courier
- Tracking
- Tracking number sent by email or SMS
- Packaging
- Discreet, tamper-evident, cold-chain available
- Duties & taxes
- Payable by the recipient on import
Only logged in customers who have purchased this product may leave a review.



Reviews
Clear filtersThere are no reviews yet.